HALIFAX, Dec. 9, 2013 /CNW/ - MedMira, Inc. (MedMira) (TSXV: MIR), a
developer of rapid diagnostic technology and solutions, today announced
the appointment of Jelle Kuypers as Chief Financial Officer.
"I'm excited to join the team at MedMira. In addition to leading the
Company's financial functions, I look forward to working with the
executive and Board to execute on the Company's strategic plan and grow
our global presence in order to increase shareholder value," said Jelle
Kuypers, Chief Financial Officer, MedMira Inc..
Kuypers brings more than 15 years of leadership experience in finance
and treasury, strategic and operational planning, as well as business
development. He has in-depth experience in creating and developing
high-performance finance teams working in global markets including
Europe, North America and the Middle East.
"On behalf of the Board of Directors, I welcome Jelle to the team and
look forward to MedMira benefiting from the wealth of financial
expertise, corporate strategy building, and international experience
that he brings," said Hermes Chan, CEO, MedMira Inc. "Jelle's focus
will be on developing a strong financial and organisational platform
across our business as we push forward with our strategic initiatives
and product launches in the US and international markets to drive
positive growth in 2014.
Chan added, "Using his extensive range of financial and business
experience, Jelle will lead the development and implementation of key
financial and business information systems aimed at streamlining
processes and increasing efficiency across the organization."
Prior to joining MedMira, Kuypers served in senior finance and treasury
roles in Canada, Switzerland and the Middle East with Rio Tinto Alcan,
Sohar Aluminum and Alcan Holdings Switzerland. He also worked for a
number of years as a management consultant with Mercer Management
Consulting and KPMG Treasury & Risk Management where he focused on the
areas of financial management, supply chain management, controlling,
and organizational redesign. He holds a master's degree in Finance and
Economics from the University of St. Gallen (HSG), graduating as lic.
oec. HSG. He also earned a CEMS Master's in International Management
(CEMS MIM) degree in International Business and Strategies and
International Controlling from the Rotterdam School of Management,
MedMira is the leading developer and manufacturer of flow-through rapid
diagnostics and technologies. MedMira is the only Canadian company to
be awarded US Army contracts for the development of rapid tests for HIV
and Hepatitis viruses. The Company's testing solutions provide
hospitals, labs, clinics and individuals with reliable, rapid diagnosis
for diseases such as HIV and hepatitis C in just three minutes. The
Company's tests are sold under the Reveal®, Multiplo™ and Miriad brands
in global markets. MedMira is located in Halifax, Nova Scotia, Canada. www.medmira.com.
This news release contains forward-looking statements, including
statements relating to growth in the Company's business, earnings and
profitability, and trends in demand for the Company's products, which
involve risk and uncertainties and reflect the Company's current
expectation regarding future events including statements regarding
possible future growth and new business opportunities. Actual events
could materially differ from those projected herein and depend on a
number of factors including, but not limited to, changing market
conditions, successful and timely completion of clinical studies,
uncertainties related to the regulatory approval process, establishment
of corporate alliances and other risks detailed from time to time in
the company quarterly filings.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE: MEDMIRA INC.
For further information:
Andrea Young, Corporate Communications